Please join us for our upcoming continuing medical education (CME) event entitled “Gynecologic Oncology Update – Look How Far We’ve Come!” on Thursday, November 14, 2024, from 5:30 to 8:30 p.m.
With the introduction of PARP inhibitors, immunotherapy, and antibody-drug conjugates (ADCs), significant strides have been made in the management of gynecologic malignancies. With our strong belief in multidisciplinary patient care, we feel that it is essential that the general medical community and our oncology colleagues have an understanding of the therapeutic regimens that are currently used in the treatment of these cancers. We will also raise awareness regarding the management of preinvasive disease as well as survivorship recommendations.
Click here for more information. Click here to register.